Alyeska Investment Group
LJPC

Alyeska Investment Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Alyeska Investment Group’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-536,847
Closed -$2.08M – 959
2020
Q4 		$2.08M Buy
536,847
+45,706
+9% +$195K 0.03% 369
2020
Q3 		$1.98M Buy
491,141
+139,716
+40% +$579K 0.03% 356
2020
Q2 		$1.5M Buy
+351,425
New +$2.14M 0.02% 374
2020
Q1 		– Sell
-643,444
Closed -$2.53M – 542
2019
Q4 		$2.53M Buy
+643,444
New +$3.8M 0.03% 280
2019
Q2 		– Sell
-315,910
Closed -$2.03M – 560
2019
Q1 		$2.03M Buy
+315,910
New +$2.06M 0.03% 284
2018
Q4 		– Sell
-125,000
Closed -$2.52M – 550
2018
Q3 		$2.52M Buy
125,000
+75,000
+150% +$1.96M 0.03% 285
2018
Q2 		$1.46M Buy
50,000
+28,925
+137% +$893K 0.01% 373
2018
Q1 		$628K Buy
+21,075
New +$680K 0.01% 412
2017
Q3 		– Sell
-80,583
Closed -$2.4M – 601
2017
Q2 		$2.4M Buy
80,583
+5,583
+7% +$160K 0.02% 334
2017
Q1 		$2.24M Buy
+75,000
New +$1.91M 0.02% 392

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Alyeska Investment Group's LJPC Position: Q1 2021 in Review

Alyeska Investment Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2021, closing a stake of 536,847 shares — an estimated $2.08M sold.

Alyeska Investment Group first reported a position in LJPC in Q1 2017 and held it in 10 quarters. The position peaked at $2.53M in Q4 2019. 76 funds tracked by Wall St. Rank hold LJPC as of Q1 2021.

  • Alyeska Investment Group reported no remaining La Jolla Pharmaceutical Company position as of Q1 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 536,847 La Jolla Pharmaceutical Company shares in Q1 2021, an estimated $2.08M.
  • Alyeska Investment Group first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 10 quarters.
  • Alyeska Investment Group's La Jolla Pharmaceutical Company position peaked at $2.53M in Q4 2019.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2021.

Based on Alyeska Investment Group's 13F filing for Q1 2021, filed 17 May 2021.